4th Annual 340B Manufacturer Summit
August 21 - 22, 2018 - Arlington MA US
Strategies and Best Practices to Strengthen Program Compliance, Effectively Communicate with Stakeholders and Prevent Revenue LeakageWith evolving regulations impacting 340B programs, pharmaceutical companies are faced with uncertainty on how to strengthen program compliance and integrity. CBI’s 4th Annual 340B Manufacturer Summit breaks down and clarifies the impending regulations, provides strategies to develop comprehensive self-disclosure response and auditing processes, and establish best practices to collaborate with contract pharmacies and covered entities.2018 brings an unprecedented focus by Congress and the Trump Administration on the size, purpose and integrity of the 340b program. Hear from National experts as the policy discussions and opportunities for input continue to evolve. From the President’s Blue Print on Drug Prices to the recently released HHS RFI, 340B remains a hot topic.